| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 1,621.35 | 1,535.46 | 1,421.85 | 1,267.61 |
| Accumulated Depreciation Total | -215.14 | -188.08 | -162.05 | -137.41 |
| Cash Equivalents | 66.75 | 71.75 | 36.84 | 82.16 |
| Other Liabilities Total | 1.37 | 0.89 | 0.51 | 1.07 |
| Accrued Expenses | 30.74 | 27.18 | 10.85 | 10.43 |
| Long Term Debt | 9.03 | 6.65 | 7.28 | 7.35 |
| Common Stock Total | 22.38 | 22.37 | 22.37 | 22.36 |
| Other Equity Total | 164.12 | 144.80 | 135.37 | 81.33 |
| Other Current Assets Total | 1.60 | 1.95 | 0.69 | 0.58 |
| Prepaid Expenses | 3.62 | 3.96 | 2.32 | 2.10 |
| Total Assets | 1,621.35 | 1,535.46 | 1,421.85 | 1,267.61 |
| Current Portof LT Debt/ Capital Leases | 7.29 | 6.91 | 6.13 | 6.15 |
| Additional Paid- In Capital | 84.02 | 82.13 | 82.13 | 81.35 |
| Cash | 27.48 | 42.00 | 60.05 | 185.36 |
| Total Equity | 1,433.10 | 1,336.37 | 1,246.69 | 1,097.35 |
| Long Term Investments | 0.07 | 0.16 | 0.16 | 0.07 |
| Retained Earnings( Accumulated Deficit) | 1,162.58 | 1,087.07 | 1,006.83 | 912.31 |
| Total Common Shares Outstanding | 11.19 | 11.18 | 11.18 | 11.18 |
| Property/ Plant/ Equipment Total- Gross | 528.03 | 493.79 | 449.37 | 407.92 |
| Tangible Book Valueper Share Common Eq | 93.61 | 85.20 | 77.35 | 65.74 |
| Goodwill Net | 333.44 | 325.29 | 320.85 | 296.06 |
| Total Liabilities | 188.25 | 199.10 | 175.16 | 170.26 |
| Total Debt | 39.35 | 47.31 | 33.50 | 34.56 |
| Short Term Investments | 500.83 | 434.22 | 387.86 | 110.59 |
| Cashand Short Term Investments | 595.05 | 547.97 | 484.76 | 378.11 |
| Total Receivables Net | 120.49 | 103.42 | 106.22 | 99.72 |
| Notes Payable/ Short Term Debt | 11.15 | 17.58 | 4.99 | 1.92 |
| Deferred Income Tax | 33.63 | 34.32 | 37.23 | 39.25 |
| Accounts Receivable- Trade Net | 115.81 | 99.25 | 100.56 | 88.26 |
| Property/ Plant/ Equipment Total- Net | 314.63 | 307.27 | 288.82 | 271.81 |
| Minority Interest | 35.57 | 34.71 | 37.48 | 43.04 |
| Total Current Liabilities | 96.76 | 106.36 | 77.57 | 60.42 |
| Total Inventory | 159.10 | 152.44 | 128.13 | 123.93 |
| Accounts Payable | 17.20 | 15.76 | 24.22 | 17.90 |
| Other Currentliabilities Total | 30.38 | 38.92 | 31.38 | 24.03 |
| Total Long Term Debt | 20.92 | 22.82 | 22.38 | 26.48 |
| Intangibles Net | 52.31 | 58.29 | 60.88 | 66.31 |
| Other Long Term Assets Total | 21.54 | 19.89 | 16.84 | 14.15 |
| Note Receivable- Long Term | 19.49 | 14.82 | 12.18 | 14.78 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 879.87 | 809.74 | 722.11 | 604.44 |
| Capital Lease Obligations | 11.89 | 16.16 | 15.10 | 19.13 |
Advanced Enzyme Technologies Dividend Advanced Enzyme Technologies Bonus Advanced Enzyme Technologies News Advanced Enzyme Technologies AGM Advanced Enzyme Technologies Rights Advanced Enzyme Technologies Splits Advanced Enzyme Technologies Board Meetings Advanced Enzyme Technologies Key Metrics Advanced Enzyme Technologies Shareholdings Advanced Enzyme Technologies Profit Loss Advanced Enzyme Technologies Cashflow Advanced Enzyme Technologies Q1 Results Advanced Enzyme Technologies Q2 Results Advanced Enzyme Technologies Q3 Results Advanced Enzyme Technologies Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks